Aerosol delivery of diethylenetriamine/nitric oxide, a nitric oxide adduct, causes selective pulmonary vasodilation in perinatal lambs

Journal of Laboratory and Clinical Medicine

Volumn 134, Issue 4, 1999, Pages 419-425

  Cornfield, David N ^a   Martin, Edward B ^b   Hampl, Vaclav ^b   Archer, Stephen L ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033213135     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90158-0     Document Type: Article

References (21)

1. 1. Rudolph A. Distribution and regulation of blood flow in the fetal and neonatal lamb. Circ Res 1985;57:811-21.
2. 2. Cassin S, Dawes GS, Mott JC, Ross BB, Strang LB. The vascular resistance of the fetal and newly ventilated lung of the lamb. J Physiol 1964;171:61-79.
3. 3. Dawes GS, Mott JC, Widdicombe JG, Wyatt DG. Changes in the lungs of the newborn lamb. J Physiol Lond 1953; 121: 141-62.
4. 4. Leftler CW, Hessler JR, Green RS. The onset of breathing at birth stimulates pulmonary vascular prostacyclin synthesis. Pediatr Res 1984;18:938-42.
5. 5. Abman SH, Chatfield BA, Hall SL, McMurtry IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990;259: H1921-7.
6. 6. Cornfield D, Chatfield B, McQueston J, McMurtry I, Abman S. Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus. Am J Physiol 1992; 262 (Heart Circ Physiol):H1474-81.
7. 7. Fineman JR, Wong J, Morin FC, Wild LM, Soifer SJ. Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. J Clin Invest 1994; 93:2675-83.
8. 8. Stenmark K, Ahman SH, Accurso FJ. Etiologic mechanisms in peristent pulmonary hypertension of the newborn. In: Pulmonary vascular physiology and pathophysiology. New York: Marcel Dekker: 1989. p. 355-402.
9. 9. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-20.
10. 10. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:818-9.
11. 11. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Maycock DE. Randomized, multicenter trial of inhaled nitric oxide in severe, persistent pumonary hypertension of the newborn. J Pediatr 1997;131:55-62.
12. 12. Roberts JJ, Fineman J, Morin FC, Shaul P, Rimar S, Schreiber MD. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997;336:605-10.
13. 13. Radi R, Beckman JS, Busli KM, Freeman B. Peroxynitrite-induced membrane lipid peroxidation. Arch Biochem Biophys 1991;288:481-7.
14. 14. Haddad I, Ischiropoulos H, Holm B, Beckman J, Baker J, Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 1993;265:L555-64.
15. 15. Morley D, Keefer LK. Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol 1993;22:S3-9.
16. 16. Kowaluk EA, Seth P, Fung H-L. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther 1992;262:916-22.
17. 17. Hampl V, Tristani-Firouzi M, Hutsell TC, Archer SL. Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension. Cardiovasc Res 1996;31:55-62.
18. 18. Christou H, Adatia I, Van Marter LJ, Kane JW, Thompson JE, Stark AR, et al. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5′-monophosphatec plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr 1997;130:603-11.
19. 19. Vanderford PA, Wong J, Chang R, Keefer LK, Soifer SJ, Fineman JR. Diethylamine/nitric oxide (NO) adduct, an NO donor, produces potent pulmonary and sytemic vasodilation in newborn lambs. J Cardiovasc Pharmacol 1994;23: 113-9.
20. 20. Pepke-Zaba J, Higenbotam T, Dinh Xuan A, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338: 1173-4.
21. 21. Oka M, Ohnishi M, Takahashi H, Soma S, Hasunuma K, Sato K. Altered vasoreactivity in lungs isolated from rats exposed to nitric oxide gas. Am J Physiol 1996;271(3 Pt 1):L419-24.